Pure Global

NAPSA Check 6 in 1 (AMP,BZO,COC,MAMP,OPI,THC) - Indonesia BPOM Medical Device Registration

NAPSA Check 6 in 1 (AMP,BZO,COC,MAMP,OPI,THC) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101011796. The device is manufactured by LUMIQUICK DIAGNOSTICS INC. from United States, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is PT. INDOMED THANKS TO JAYA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : C
NAPSA Check 6 in 1 (AMP,BZO,COC,MAMP,OPI,THC)
Analysis ID: AKL 20101011796

Risk Classification

Kelas Resiko : C

Product Class

Kelas : 2

Country of Origin

United States

Authorized Representative

PT. INDOMED THANKS TO JAYA

AR Address

Rukan Avenue 8-178 Jakarta Garden City, Cakung Timur, Cakung JAKARTA TIMUR

Registration Date

Aug 10, 2021

Expiry Date

Aug 10, 2024

Product Type

Clinical Toxicology Test System

Multi parameter clinical toxicology test system

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing